IN THE NEWS: Dr. Zonder on the Outcomes of the PERSEUS Trial in Multiple Myeloma


Jeffrey Zonder, M.D., hematologist, leader of the Multiple Myeloma and Amyloidosis Multidisciplinary Team and member of the Hematology Oncology Multidisciplinary Team at Karmanos, discussed the results of the phase 3 PERSEUS trial with OncLive TV. The findings from the investigation were presented at the 2023 American Society of Hematology Annual Meeting.

Watch here.